期刊文献+

激活血管平滑肌细胞OX40-OX40L系统对其增殖及迁移能力的影响 被引量:1

Effects of OX40-OX40L system activation on proliferation and migration of cultured rat aortic vascular smooth muscle cells
原文传递
导出
摘要 目的研究OX40-OX40L轴的激活对大鼠血管平滑肌细胞(VSMC)增殖和迁移能力的影响。方法原代培养大鼠主动脉VSMC并传代,培养液中添加OX40L(0、0.1、1、10或20mg/L)刺激24h,或在培养基中加入选定浓度OX40L10mg/L,刺激6、12、24、36、48h。以CCK-8法测定VSMC增殖率,以划痕法测定VSMC迁移率。结果在OX40L浓度从0~20mg/L范围内,刺激24h后,VSMC的增殖、迁移能力的增强与OX40L浓度呈剂量依赖性,并明显大于OX40L0mg/L组(P<0.05)。OX40L浓度达到10mg/L时,VSMC的增殖、迁移能力已接近最大值。应用10mg/L的OX40L刺激不同时间(6、12、24、36、48h)后,发现随着刺激时间的延长,VSMC增殖、迁移能力逐渐增强;刺激至24h,VSMC增殖能力达到最大值。结论 OX40-OX40L轴的激活可能通过促进VSMC的增殖及迁移影响动脉粥样斑块的进展。 Objective To investigate the effects of OX40-OX40 ligand activation on the proliferation and migration of primarily cultured aortic vascular smooth muscle cells(VSMCs) in rats.Methods The VSMCs were cultured and passaged.The OX40L in the varied concentrations of 0 to 20 mg/L was added into culture medium and cultured for 24 hours,or OX40L 10 mg/L was added into culture medium and cultured for 6 to 48 hours.The proliferation and migration of VSMCs were detected by CCK-8 kits and wound-healing assay.Results The proliferation and migration of VSMCs were significantly increased by OX40L stimulation in a dose-dependent manner,which reached the maximum when concentration of OX40L was 10 mg/L(P〈0.05).The maximum rates of proliferation and migration of VSMCs were seen when OX40L 10 mg/L was used to activate OX40-OX40L system for 24 hours(P〈0.05).Conclusion The activating of OX40-OX40L system promotes the proliferation and migration of VSMCs,which may affect the progress of artherosclerosis plaque.
作者 于文敏
出处 《江苏医药》 CAS CSCD 北大核心 2011年第20期2369-2371,共3页 Jiangsu Medical Journal
关键词 OX40 OX40L 血管平滑肌细胞 OX40 OX40L Aortic vascular smooth muscle cells
  • 相关文献

参考文献9

  • 1Gotsman I, Sharpe AH, Lichtman AH. T-cell costimulation and coinhibition in atheroselerosis[J]. Circulation Research, 2008,103 (11) : 1220-1231.
  • 2Olofsson PS, Soderstrom LA, Wagsater D, et al. CD137 is expressed in human atherosclerosis and promotes develop- ment of plaque inflammation in hypercholesterolemic mice [J]. Circulation, 2008,117 (10) : 1292-1301.
  • 3Wang X, Ria M, Kelmenson PM, et al. Positional identifica- tion of TNFSF4, encoding OX40 ligand, as a gene that influ- ences atherosclerosis susceptibility[J]. Nature Genetics, 2005,37(4) : 365-372.
  • 4Ria M, Eriksson P, Boquist S, et al. Human genetic evidence that OX40 is implicated in myocardial infarction[J]. Bio- chemical and Biophysical Research Communications, 2006, 339(3) : 1001-1006.
  • 5Aminian A, Kabir T, Eeckhout E. Treatment of drug-eluting stent restenosis: an emerging challenge[J]. Catheter Cardio- vasc Interv, 2009,74(1) : 108-116.
  • 6Stintzing S, Ocker M, Hartner A, et al. Differentiation patterning of vascular smooth muscle cells(VSMC) in ather- osclerosis[J]. Virchows Arch, 2009,455 (2) : 171-185.
  • 7Nakano M, Fukumoto Y, Satoh K, et al. OX40 ligand plays an important role in the development of atheroselerosis through vasa vasorum neovaseularization[J]. Cardiovascular Research, 2010,88(3) : 539-546.
  • 8Jeon HJ, Choi JH, Jung IH, et al. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice[J]. Circula- tion, 121(9) : 1124-1133.
  • 9严金川,丁澍,梁仪,刘培晶,任国庆,朱建,马根山.CD40-CD40配体对大鼠主动脉平滑肌细胞增殖及迁移影响[J].临床心血管病杂志,2007,23(11):854-857. 被引量:3

二级参考文献16

  • 1YAN J C,ZHU J,GAO L,et al.The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes[J].Clin Chim Acta,2004,343:155-159.
  • 2YAN J C,WU Z G,KONG X T,et al.Relation between upregulation of CD40-CD40 ligand system and serum levels of matrix metalloproteinases and complex stenosis morphology in patients with acute coronary syndrome[J].Acta Pharmaco Sin,2004,25:251-256.
  • 3TURKER S,GUNERI S,AKDENIZ B,et al.Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease[J].Am J Cardiol,2006,97:198-202.
  • 4L'ALLIER P L,TARDIF J C,GREGOIRE J,et al.Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis[J].Can J Cardiol,2005,21:495-500.
  • 5YAN J C,WU Z G,KONG X T,et al.Effect of CD40-CD40 ligand interaction on diacylglycerol-protein kinase C signal transduction pathway and intracellular calcium in cultured human monocytes[J].Acta Pharmacol Sin,2003,24:687-691.
  • 6YAN J C,WU Z G,KONG X T,et al.Effect of CD40-CD40 ligand interaction on diacylglycerol-protein kinase C and inositol trisphosphate-Ca(2+) signal transduction pathway in human umbilical vein endothelial cells[J].Clin Chim Acta,2003,37:133-140.
  • 7SKOWASCH D,JABS A,ANDRIE R,et al.Pathogen burden,inflammation,proliferation and apoptosis in human in-stent restenosis[J].J Vasc Res,2004,41:525-534.
  • 8MARTIN R B.In-stent stenosis:pathology and implications for the development of drug eluting stents[J].Heart,2003,89:218-224.
  • 9CAMPBELL J C,CAMPBELL G R,ROSS R.The smooth muscle cell in culture[J].Physil Rev,1979,59:1-60.
  • 10TROCHON V,MABILAT C,BERTRAND P,et al.Evidence of involvement of CD44 in endothelial cell proliferation,migration and angiogeness in vitro[J].Int J Cancer,1996,66:664-668.

共引文献2

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部